Answers are grounded in this paper and cite their sources.
Randomized trial finds metformin reduces insulin resistance more effectively than N-acetylcysteine in infertile women with PCOS, indicating N-acetylcysteine is a viable alternative.
Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder and insulin resistance (IR) is central to its pathogenesis. Although metformin is widely used as an insulin sensitizer, gastrointestinal adverse effects may limit adherence. N-acetylcysteine (NAC), having insulin-sensitizing properties, has emerged as a potential alternative, but comparative evidence remains limited. Objective: To compare the efficacy of NAC and metformin, each combined with clomiphene citrate, on IR, hormonal and metabolic profiles, oxidative stress, ovulation, and pregnancy outcomes in infertile women with PCOS. Materials and Methods: In this randomized, single-blind controlled trial, 169 infertile women with PCOS were randomized to receive NAC (600 mg three times daily) or metformin (500 mg three times daily), each combined with clomiphene citrate for 6 months. The primary outcome was change in 2-h postglucose serum insulin. Secondary outcomes included ovulation, clinical pregnancy, hormonal and metabolic parameters, oxidative stress and adverse events. Results: Of 343 women screened, 169 were randomized; 166 completed the study. Both treatments significantly improved glucose metabolism, IR, lipid profile, oxidative stress, and ovulation. Metformin produced greater reductions in Luteinizing hormone, testosterone, and 2-h postglucose insulin than NAC (28.48 vs. 16.64 µIU/mL; P = 0.037). Clinical pregnancy rates were higher with metformin (34.9% vs. 22.9%), although the difference was not statistically significant. No serious adverse events occurred. Conclusions: Both NAC and metformin improved metabolic, hormonal, and reproductive outcomes. Metformin was superior in reducing postprandial IR and hyperandrogenism, whereas NAC may be a safe alternative for women intolerant to metformin. Larger multicenter trials are needed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Saxena et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: